{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:07:06Z","timestamp":1791230826527,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.010","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:14:58Z","timestamp":1292663698000},"page":"1115-1121","source":"Crossref","is-referenced-by-count":46,"title":["The Global Pertussis Initiative: Report from a Round Table Meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11\u201312 January 2010"],"prefix":"10.1016","volume":"29","author":[{"given":"Nicole","family":"Guiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Heinz","family":"Wirsing von K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.inf.0000160707.44131.ae","article-title":"The global pertussis initiative: process overview","volume":"24","author":"Plotkin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2010.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/426020","article-title":"New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative","volume":"39","author":"Forsyth","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2010.12.010_bib0015","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2006.12.017","article-title":"Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting","volume":"25","author":"Forsyth","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.010_bib0020","first-page":"73","article-title":"Pertussis\u2014United States, 1997\u20132000","volume":"51","author":"CDC","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0025","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1086\/514776","article-title":"Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990\u20131996","volume":"28","author":"Guris","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.12.010_bib0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"von Konig","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0035","first-page":"215","article-title":"Surveillance de la coqueluche \u00e0 l\u2019h\u00f4pital en 1997","volume":"50","author":"Baron","year":"1998","journal-title":"Bull Epidemiol Heb"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0040","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/01.inf.0000160912.58660.87","article-title":"Health burden of pertussis in adolescents and adults","volume":"24","author":"Rothstein","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.010_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.010_bib0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/652281","article-title":"Pertussis disease burden in the household: how to protect young infants","volume":"50","author":"de Greeff","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.010_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.112.2.405","article-title":"The science and fiction of the resurgence of pertussis","volume":"112","author":"Cherry","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.prrv.2008.05.010","article-title":"Pertussis: review of epidemiology, diagnosis, management and prevention","volume":"9","author":"Wood","year":"2008","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0065","unstructured":"Octavia S, Maharjan RP, Sintchenko V, Stevenson G, Reeves PR, Gilbert GL, et al. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol. 2001."},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.010_bib0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/644733","article-title":"Bordetella pertussis and pertussis vaccines","volume":"49","author":"Guiso","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2010.12.010_bib0075","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.010_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","article-title":"Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen","volume":"10","author":"Mooi","year":"2010","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.010_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1086\/315192","article-title":"Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies","volume":"181","author":"Brennan","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.010_bib0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis","volume":"174","author":"Galanis","year":"2006","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.010_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/14712598.6.7.685","article-title":"Pertussis immunisation in adolescents and adults\u2014Bordetella pertussis epidemiology should guide vaccination recommendations","volume":"6","author":"Heininger","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-9-22","article-title":"The epidemiology of pertussis in Germany: past and present","volume":"9","author":"Hellenbrand","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0105","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/infdis\/169.6.1297","article-title":"Pertussis in Massachusetts, 1981\u20131991: incidence, serologic diagnosis, and vaccine effectiveness","volume":"169","author":"Marchant","year":"1994","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.010_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpedi.1994.02170020039006","article-title":"Outbreak of pertussis in a fully immunized adolescent and adult population","volume":"148","author":"Mink","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.vaccine.2010.12.010_bib0115","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.2807\/esm.12.11.00748-en","article-title":"Nosocomial infections and community clusters of pertussis in France, 2000\u20132005","volume":"12","author":"Bonmarin","year":"2007","journal-title":"Eur Surveill"},{"issue":"1.","key":"10.1016\/j.vaccine.2010.12.010_bib0120","article-title":"Pertussis surveillance in French hospitals: results from a 10 year period","volume":"12","author":"Bonmarin","year":"2007","journal-title":"Eur Surveill"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/CDLI.11.6.1045-1053.2004","article-title":"Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States","volume":"11","author":"Baughman","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0130","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0135","series-title":"Presented at 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)","article-title":"Pertussis among adolescents and adults followed in general practice in a regional French sample, in 2008","author":"Lasserre","year":"2010"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006454-199805000-00013","article-title":"Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination","volume":"17","author":"Baron","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0145","first-page":"121","article-title":"Calendrier vaccinal 2004. Avis du Conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France","volume":"28\u201329","year":"2004","journal-title":"Bull Epidemiol Heb"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.010_bib0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.medmal.2008.04.001","article-title":"Are pertussis vaccination guidelines applied to adults and health care workers?","volume":"38","author":"Rioja","year":"2008","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0155","first-page":"123","article-title":"Le Calendrier des vaccinations et les recommandations vaccinales 2010 selon l\u2019avis du Haut conseil de la sant\u00e9 publique","volume":"14\u201315","year":"2010","journal-title":"Bull Epidemiol Heb"},{"issue":"50","key":"10.1016\/j.vaccine.2010.12.010_bib0160","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1055\/s-2006-957208","article-title":"Pertussis: incidence, symptoms and costs","volume":"131","author":"Riffelmann","year":"2006","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e318161a2b9","article-title":"Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands","volume":"27","author":"de Greeff","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0170","unstructured":"Pertussis vaccine schedules across Europe. Eur Surveill. Accessed June 14, 2010. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=2567."},{"key":"10.1016\/j.vaccine.2010.12.010_bib0175","unstructured":"Pertussis incidence in the Netherlands after introduction of an acellular booster vaccination at 4 years of age. Eur Surveill. Accessed June 14, 2010. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=2496."},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2010.12.010_bib0180","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0264-410X(02)00777-6","article-title":"Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine","volume":"21","author":"Olin","year":"2003","journal-title":"Vaccine"},{"issue":"9091","key":"10.1016\/j.vaccine.2010.12.010_bib0185","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2010.12.010_bib0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0200","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0205","unstructured":"Data and statistics. The Swedish Institute for Infectious Disease Control. Accessed 16 September 2010. http:\/\/smi.se\/in-english\/statistics\/."},{"key":"10.1016\/j.vaccine.2010.12.010_bib0210","series-title":"Presented at 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)","article-title":"Incidence of pertussis in childhood after primary and booster vaccinations","author":"Rydevik","year":"2010"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0215","unstructured":"Case definitions for infectious conditions under public health surveillance. Morb Mortal Wkly Rep. Accessed June 14 2010. http:\/\/wonder.cdc.gov\/wonder\/prevguid\/m0047449\/m0047449.asp."},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0220","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1086\/315863","article-title":"The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989\u20131998","volume":"182","author":"Yih","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0225","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3122\/jabfm.19.6.603","article-title":"Pertussis infection in the United States: role for vaccination of adolescents and adults","volume":"19","author":"Brooks","year":"2006","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/653938","article-title":"Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis","volume":"51","author":"Wei","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0235","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/341511","article-title":"Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage","volume":"186","author":"Gilberg","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0240","series-title":"Presented at 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)","article-title":"2006\u20132009: Pertussis Paediatric Surveillance, in Private Practice, in France","author":"Guiso","year":"2010"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0245","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.inf.0000160926.89577.3b","article-title":"Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives","volume":"24","author":"Cherry","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0250","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JCM.02187-07","article-title":"Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007","volume":"46","author":"Andre","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.010_bib0255","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/JCM.00817-09","article-title":"Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses","volume":"47","author":"Caro","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.010_bib0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/JCM.38.1.467-467.2000","article-title":"Detection of Bordetella holmesii using Bordetella pertussis IS481 PCR assay","volume":"38","author":"Loeffelholz","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0265","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/JCM.39.5.1963-1966.2001","article-title":"Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii","volume":"39","author":"Reischl","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.010_bib0270","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JCM.43.10.4925-4929.2005","article-title":"Nucleic acid amplification tests for diagnosis of Bordetella infections","volume":"43","author":"Riffelmann","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.010_bib0275","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.vaccine.2008.11.072","article-title":"International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19\u201320 July 2007","volume":"27","author":"Tondella","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0280","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CDLI.7.3.422-426.2000","article-title":"Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","volume":"7","author":"Kosters","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0285","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/JCM.01371-10","article-title":"Performance of commercial enzyme-linked immunosorbent assays for the detection of antibodies to Bordetella pertussis","volume":"48","author":"Riffelmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2010.12.010_bib0290","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","author":"Guiso","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.12.010_bib0295","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/CVI.00248-09","article-title":"Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection","volume":"16","author":"Menzies","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.010_bib0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/CVI.00372-08","article-title":"Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study","volume":"16","author":"Xing","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.12.010_bib0305","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1099\/jmm.0.46543-0","article-title":"Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults","volume":"55","author":"Litt","year":"2006","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.medmal.2009.01.006","article-title":"Awareness and adherence to pertussis vaccination guidelines by occupational medicine physicians in Paris healthcare institution","volume":"39","author":"Lasserre","year":"2009","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.010_bib0315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ypmed.2010.04.001","article-title":"Pertussis prevention and diagnosis practices for adolescents and adults among a national sample of French general practitioners","volume":"51","author":"Lasserre","year":"2010","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.010_bib0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/hv.5.5.6911","article-title":"Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial","volume":"5","author":"Beytout","year":"2009","journal-title":"Hum Vaccin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T22:21:16Z","timestamp":1637014876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10017482"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}